ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

The Journey Pregnancy App by Emagine Solutions Technology Adds Revolutionary Mobile Vitals Scanner

The cutting-edge FDA-cleared technology from FaceHeart enables pregnant women to take their blood pressure and maternal health vital signs, directly from the app without the need for any equipment

Continuing its mission to become one of the nation’s most empowering pregnancy tools, Emagine Solutions Technology announces its partnership with FaceHeart to add the powerful new vitals scanning technology to its signature app – The Journey Pregnancy. Now, app users can scan themselves via their mobile device cameras and measure key vitals, allowing for easier health monitoring for those navigating gaps in care.

FaceHeart is a company committed to improving human health through its FDA 510(k)-cleared, AI-driven, video-based contactless vital signs scanning technology. By integrating FaceHeart Vitals™ into The Journey Pregnancy’s “Vital View”, users can access its capabilities with a touch on the screen, taking a 50-second selfie video that captures six critical maternal health vital signs: Heart Rate (HR), Blood Pressure (BP), Respiration Rate (RR), Oxygen Saturation (SpO2), Heart Rate Variability (HRV), and Stress Index. These vitals can then be recorded in the app to track maternal health trends over time or (at their discretion) shared with doctors between office visits via the app’s EPIC integration. This will give women and healthcare providers an opportunity to have visibility into and address common pregnancy concerns before they become acute – including hypertension and preeclampsia.

In its continuing mission to promote better access to maternal health tools, Emagine Solutions Technology is offering the technology free through the entire month of July (2025).

So far, FaceHeart has obtained two FDA 510(k) clearances under the category of Class II SaMD (Software as a Medical Device), one for pulse (heart) rate measurement (k223633) and the other for respiratory rate measurement (k243966). Leveraging edge computing, FaceHeart Vitals™ extracts user's facial images for a fraction of a second, conducts the corresponding vital sign measurements through their AI-driven, medical-graded algorithms in real-time, then discards the facial images upon completion. Emagine has built their platform with privacy top of mind, ensuring HIPAA compliance and adherence to the highest standards of patient data privacy.

The Journey Pregnancy App is available for free at Apple’s App Store and Google Play. For more info, visit: thejourney.health.

About Emagine Solutions Technology

Emagine is an award-winning company tackling the maternal health crisis with technology to make pregnancy care safer, lower cost, and improve outcomes. The Journey Pregnancy, our AI-powered maternal health app and remote patient monitoring platform, is your companion for a safe pregnancy. Our technology helps women manage their maternal health through pregnancy and postpartum. To find out more, visit emaginest.com and follow Emagine on Instagram, Twitter, TikTok, LinkedIn and Facebook.

Now, without any equipment needed, The Journey Pregnancy app users will be able to scan themselves with their mobile device cameras and measure key vitals, allowing for easier health monitoring for those navigating gaps in care.

Contacts

Recent Quotes

View More
Symbol Price Change (%)
AMZN  226.19
-4.09 (-1.78%)
AAPL  278.28
+0.25 (0.09%)
AMD  210.80
-10.63 (-4.80%)
BAC  55.14
+0.58 (1.06%)
GOOG  310.52
-3.18 (-1.01%)
META  644.23
-8.48 (-1.30%)
MSFT  478.53
-4.94 (-1.02%)
NVDA  175.02
-5.91 (-3.27%)
ORCL  189.97
-8.88 (-4.47%)
TSLA  459.16
+12.27 (2.75%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.